Wajda, B.G.; Ferrie, L.E.; Abbott, A.G.; Elmi Assadzadeh, G.; Monument, M.J.; Kendal, J.K.
Denosumab vs. Zoledronic Acid for Metastatic Bone Disease: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers 2025, 17, 388.
https://doi.org/10.3390/cancers17030388
AMA Style
Wajda BG, Ferrie LE, Abbott AG, Elmi Assadzadeh G, Monument MJ, Kendal JK.
Denosumab vs. Zoledronic Acid for Metastatic Bone Disease: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers. 2025; 17(3):388.
https://doi.org/10.3390/cancers17030388
Chicago/Turabian Style
Wajda, Benjamin G., Leah E. Ferrie, Annalise G. Abbott, Golpira Elmi Assadzadeh, Michael J. Monument, and Joseph K. Kendal.
2025. "Denosumab vs. Zoledronic Acid for Metastatic Bone Disease: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials" Cancers 17, no. 3: 388.
https://doi.org/10.3390/cancers17030388
APA Style
Wajda, B. G., Ferrie, L. E., Abbott, A. G., Elmi Assadzadeh, G., Monument, M. J., & Kendal, J. K.
(2025). Denosumab vs. Zoledronic Acid for Metastatic Bone Disease: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers, 17(3), 388.
https://doi.org/10.3390/cancers17030388